Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Bernadette Maynadier"'
Autor:
Philippe Hermann, Louise Roques, Laurence Barthe, Laishun Chen, Isabelle Hude, Bernadette Maynadier, Valérie Brunner, Sébastien Séguier
Publikováno v:
Drug Design, Development and Therapy
Valérie Brunner,1 Bernadette Maynadier,2 Laishun Chen,3 Louise Roques,2 Isabelle Hude,2 Sébastien Séguier,2 Laurence Barthe,1 Philippe Hermann11Pierre Fabre Médicament, Centre de R&D, Toulouse, 2Centre Experimental PreClinque, Campans, France; 3F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce8b3e8b0050d7349ce0ecb62f3c2613
http://europepmc.org/articles/PMC4484650
http://europepmc.org/articles/PMC4484650
Autor:
Lysiane Troncy, Bernadette Maynadier, Guillaume Picard, Christine Lacheny, Alain Beck, Michel Jaquinod, Dorothée Lebert, Virginie Brun, Christine Klinguer-Hamour, Walter Low, Nicolas Mouz, Charlotte Beau-Larvor
Publikováno v:
Bioanalysis
Bioanalysis, Future Science, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Bioanalysis, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Bioanalysis, Future Science, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Bioanalysis, 2015, 7 (10), pp.1237-1251. ⟨10.4155/bio.15.56⟩
Background: In preclinical studies, monoclonal antibodies (mAbs) are traditionally assayed by ligand-binding-assays. Recently, quantitative liquid chromatography mass spectrometry (MS)-based assays have emerged which circumvent a number of challenges
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5531ecf6388f66098f9079cb40d7a990
https://hal.archives-ouvertes.fr/hal-02086282
https://hal.archives-ouvertes.fr/hal-02086282
